Viewing Study NCT02375568


Ignite Creation Date: 2025-12-24 @ 5:44 PM
Ignite Modification Date: 2026-01-06 @ 2:09 AM
Study NCT ID: NCT02375568
Status: UNKNOWN
Last Update Posted: 2015-03-02
First Post: 2015-02-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Large-scale Expansion and Characterization of Mesenchymal Stem Cells for Clinical Application
Sponsor: Chin-Hung Chang
Organization:

Study Overview

Official Title: Large-scale ex Vivo Expansion and Characterization of Synovial Membrane Mesenchymal Stem Cells (SM-MSC) and Infrapatellar Fat Pad Mesenchymal Stem Cells (IF-MSC) for Clinical Application
Status: UNKNOWN
Status Verified Date: 2015-02
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: According to many recent research, mesenchymal stem cells (MSC) isolated from synovial membrane and infrapatellar fat pad have higher ex vivo proliferation capacity, multipotency and ability to undergo chondrogenesis.

Based on this concept, the investigators plan to get two removed tissues (synovial membrane and infrapatellar fat pad) from patients who have an operation of total knee replacement. The investigators are going to isolate and expand MSC from these two tissues respectively, and then compare the chondrogenesis ability for clinical application. In the other hand, the investigators plan to build techniques and procedures which comply with "Good Tissue Practices (GTP)"
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: